1. Home
  2. CYCC vs LNZA Comparison

CYCC vs LNZA Comparison

Compare CYCC & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • LNZA
  • Stock Information
  • Founded
  • CYCC 1992
  • LNZA 2005
  • Country
  • CYCC Malaysia
  • LNZA United States
  • Employees
  • CYCC N/A
  • LNZA N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • LNZA Major Chemicals
  • Sector
  • CYCC Health Care
  • LNZA Industrials
  • Exchange
  • CYCC Nasdaq
  • LNZA Nasdaq
  • Market Cap
  • CYCC 61.2M
  • LNZA 58.0M
  • IPO Year
  • CYCC N/A
  • LNZA N/A
  • Fundamental
  • Price
  • CYCC $1.63
  • LNZA $0.28
  • Analyst Decision
  • CYCC
  • LNZA Hold
  • Analyst Count
  • CYCC 0
  • LNZA 2
  • Target Price
  • CYCC N/A
  • LNZA $2.00
  • AVG Volume (30 Days)
  • CYCC 191.0K
  • LNZA 3.0M
  • Earning Date
  • CYCC 05-15-2025
  • LNZA 05-19-2025
  • Dividend Yield
  • CYCC 147.24%
  • LNZA N/A
  • EPS Growth
  • CYCC N/A
  • LNZA N/A
  • EPS
  • CYCC N/A
  • LNZA N/A
  • Revenue
  • CYCC $14,000.00
  • LNZA $48,831,000.00
  • Revenue This Year
  • CYCC $137.21
  • LNZA $86.52
  • Revenue Next Year
  • CYCC N/A
  • LNZA N/A
  • P/E Ratio
  • CYCC N/A
  • LNZA N/A
  • Revenue Growth
  • CYCC N/A
  • LNZA N/A
  • 52 Week Low
  • CYCC $1.36
  • LNZA $0.14
  • 52 Week High
  • CYCC $49.34
  • LNZA $3.15
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 32.89
  • LNZA 56.68
  • Support Level
  • CYCC $1.36
  • LNZA $0.19
  • Resistance Level
  • CYCC $1.94
  • LNZA $0.26
  • Average True Range (ATR)
  • CYCC 0.43
  • LNZA 0.04
  • MACD
  • CYCC -0.07
  • LNZA 0.01
  • Stochastic Oscillator
  • CYCC 8.31
  • LNZA 42.00

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.

Share on Social Networks: